Business Description
InventisBio Co Ltd
ISIN : CNE100005Q22
Share Class Description:
SHSE:688382: Class ACompare
Compare
Traded in other countries / regions
688382.China IPO Date
2022-07-25Description
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 66.91 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Altman Z-Score | 23.25 | |||||
| Beneish M-Score | 0.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 39.3 | |||||
| 3-Year FCF Growth Rate | -7.1 | |||||
| 3-Year Book Growth Rate | 16.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 23.34 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.21 | |||||
| 9-Day RSI | 51.16 | |||||
| 14-Day RSI | 52.81 | |||||
| 6-1 Month Momentum % | 42.56 | |||||
| 12-1 Month Momentum % | -29.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.77 | |||||
| Quick Ratio | 13.77 | |||||
| Cash Ratio | 12.21 | |||||
| Days Sales Outstanding | 761.85 | |||||
| Days Payable | 3479.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.7 | |||||
| Shareholder Yield % | 0.21 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.93 | |||||
| Operating Margin % | -483.37 | |||||
| Net Margin % | -448.98 | |||||
| FCF Margin % | -472.9 | |||||
| ROE % | -18.3 | |||||
| ROA % | -16.96 | |||||
| ROIC % | -268.05 | |||||
| ROC (Joel Greenblatt) % | -453.39 | |||||
| ROCE % | -18.96 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 94.66 | |||||
| PB Ratio | 4.12 | |||||
| Price-to-Tangible-Book | 4.12 | |||||
| EV-to-EBIT | -14.48 | |||||
| EV-to-EBITDA | -14.48 | |||||
| EV-to-Revenue | 67.69 | |||||
| EV-to-FCF | -14.97 | |||||
| Price-to-Net-Current-Asset-Value | 4.28 | |||||
| Price-to-Net-Cash | 4.88 | |||||
| Earnings Yield (Greenblatt) % | -6.91 | |||||
| FCF Yield % | -5.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InventisBio Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 77.513 | ||
| EPS (TTM) (Â¥) | -0.6 | ||
| Beta | 0 | ||
| Volatility % | 57.35 | ||
| 14-Day RSI | 52.81 | ||
| 14-Day ATR (Â¥) | 0.819956 | ||
| 20-Day SMA (Â¥) | 12.694 | ||
| 12-1 Month Momentum % | -29.78 | ||
| 52-Week Range (Â¥) | 6.5 - 15.49 | ||
| Shares Outstanding (Mil) | 576.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InventisBio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InventisBio Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
InventisBio Co Ltd Frequently Asked Questions
What is InventisBio Co Ltd(SHSE:688382)'s stock price today?
The current price of SHSE:688382 is ¥12.40. The 52 week high of SHSE:688382 is ¥15.49 and 52 week low is ¥6.50.
When is next earnings date of InventisBio Co Ltd(SHSE:688382)?
The next earnings date of InventisBio Co Ltd(SHSE:688382) is .
Does InventisBio Co Ltd(SHSE:688382) pay dividends? If so, how much?
InventisBio Co Ltd(SHSE:688382) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers